LIVE

BNTX

BioNTech SE

BNTX

NASDAQ·Healthcare·Biotechnology·Mkt cap $23.8B

$97.86

▲ +4.20%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$79.52 - $124.00

P/E

-19.23

Fwd P/E

-20.13

Beta

1.32

Div Yield

0.00%

Avg Vol

956.7K

Shares Out

251.3M

Mkt Cap

$23.8B

Price action

Price chart

Down 13.3% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

2 reasons

  • High barriers to entry (70%+ gross margins)
  • Established market position
▼

Bear Case

1 risk

  • Average volatility.

Growth

Revenue decline expected

Positive revenue trend

Value

Deep value opportunity - significant discount to Biotech & Therapeutics peers

Momentum

Stable

+3.0% over 3m

Quality

Excellent

Strong fundamentals

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 3, 2026

“
Q2 26 RECAP

MAY 5, 2026

Reported EPS of -$2.43 vs -$2.52 consensus (+3.7% surprise). Revenue of $136.4M vs $207.4M expected (-34.2%).

EPS beat +3.7%
Revenue miss

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+3.7%

Next: Aug 3, 2026

Revenue trend · last 8Q

—

—

—

-3%

+103%

+22%

-24%

-34%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$128.7M

$1.2B

$1.2B

$182.8M

$260.8M

$1.5B

$898.9M

$120.0M

Margins · last 8Q

Gross

—

Operating

—

Profit

-450.4%

View full earnings history →

Wall Street consensus

9 analysts · 89% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

8

89%

Hold

1

11%

Sell

0%

Median Price Target

$130.50

▲ +33.4% vs $97.86

Low $96.00
Median $130.50
High $158.00

Latest: UBS · $135.00 · May 27, 2026

4 analysts covering

View full analyst page →

vs Industry

How BNTX stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.